An OMV-Based Nanovaccine Confers Safety and Protection against Pathogenic Escherichia coli via Both Humoral and Predominantly Th1 Immune Responses in Poultry.
An OMV-Based Nanovaccine Confers Safety and Protection against Pathogenic Escherichia coli via Both Humoral and Predominantly Th1 Immune Responses in Poultry.
复制标题
基于 OMV 的纳米疫苗通过家禽的体液免疫反应和以 Th1 为主的免疫反应,提供安全性和针对致病性大肠杆菌的保护。
DOI:
10.3390/nano10112293
复制
发表时间:
2020-11-20
期刊:
影响因子:
--
通讯作者:
Yang M
中科院分区:
文献类型:
--
作者:
Hu R;Liu H;Wang M;Li J;Lin H;Liang M;Gao Y;Yang M
Avian pathogenic Escherichia coli (APEC) infection in poultry causes enormous economic losses and public health risks. Bacterial outer membrane vesicles (OMVs) and nano-sized proteolipids enriched with various immunogenic molecules have gained extensive interest as novel nanovaccines against bacterial infections. In this study, after the preparation of APEC O2-derived OMVs (APEC_OMVs) using the ultracentrifugation method and characterization of them using electron microscopy and nanoparticle tracking analyses, we examined the safety and vaccination effect of APEC_OMVs in broiler chicks and investigated the underlying immunological mechanism of protection. The results showed that APEC_OMVs had membrane-enclosed structures with an average diameter of 89 nm. Vaccination with 50 μg of APEC_OMVs had no side effects and efficiently protected chicks against homologous infection. APEC_OMVs could be effectively taken up by chicken macrophages and activated innate immune responses in macrophages in vitro. APEC_OMV vaccination significantly improved activities of serum non-specific immune factors, enhanced the specific antibody response and promoted the proliferation of splenic and peripheral blood lymphocytes in response to mitogen. Furthermore, APEC_OMVs also elicited a predominantly IFN-γ-mediated Th1 response in splenic lymphocytes. Our data revealed the involvement of both non-specific immune responses and specific antibody and cytokine responses in the APEC_OMV-mediated protection, providing broader knowledge for the development of multivalent APEC_OMV-based nanovaccine with high safety and efficacy in the future.
登录
查看更多内容
DOI:
10.1038/nrmicro3480
发表时间:
2015-10
期刊:
Nature reviews. Microbiology
影响因子:
--
作者:
Brown L;Wolf JM;Prados-Rosales R;Casadevall A
通讯作者:
Casadevall A
影响因子:
4.4
作者:
Avalos-Gomez, Christian;Reyes-Lopez, Magda;de la Garza, Mireya
通讯作者:
de la Garza, Mireya
影响因子:
4.4
作者:
Hoelzer K;Bielke L;Blake DP;Cox E;Cutting SM;Devriendt B;Erlacher-Vindel E;Goossens E;Karaca K;Lemiere S;Metzner M;Raicek M;Collell Suriñach M;Wong NM;Gay C;Van Immerseel F
通讯作者:
Van Immerseel F
影响因子:
4.6
作者:
Huang W;Wang S;Yao Y;Xia Y;Yang X;Li K;Sun P;Liu C;Sun W;Bai H;Chu X;Li Y;Ma Y
通讯作者:
Ma Y
影响因子:
3.7
作者:
Ebrahimi-Nik H;Bassami MR;Mohri M;Rad M;Khan MI
通讯作者:
Khan MI